查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2059309

神經技術市場：市場洞察、競爭格局與市場預測（2034 年）

Neurotechnology - Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

神經技術市場概述

  • 全球神經技術市場預計將從 2025 年的 172.4061 億美元成長到 2034 年的 570.2968 億美元，展現出強勁且持續的成長動能。
  • 全球神經技術市場預計在 2026 年至 2034 年的預測期內將以 14.26% 的年複合成長率成長。
  • 帕金森氏症、癲癇和阿茲海默症神經系統疾病的日益普遍，顯著提升了對先進診斷和治療方案的需求，推動了神經技術的應用。同時，腦機介面（BCI）和神經影像系統等領域的持續技術進步，提高了這些方案的準確性、效率和易用性，使其在臨床和非臨床環境中都能得到更廣泛的應用。此外，對Neuralink和Synchron等創新公司的投資和資金籌措不斷增加，加速了產品開發、商業化和全球擴張。這些因素共同建構了一個強大的生態系統，支持創新，促進應用，並推動神經技術市場的整體成長。
  • 在神經技術市場中營運的主要公司包括：Neuralink Corp.、Synchron Inc.、Paradromics Inc.、Blackrock Neurotech LLC、Kernel Inc.、Emotiv Inc.、NeuroSky Inc.、OpenBCI Inc.、Neurable Inc.、BrainCoitor Inc.、NextMind (Snaptb Inc.)、Bitbtec Technologies Inc. engineering GmbH、Natus Medical Incorporated、Nihon Kohden Corporation、Medtronic plc、Abbott Laboratories 和 Boston Scientific Corporation。
  • 北美地區預計將引領神經技術市場的發展，這得益於其先進的醫療保健基礎設施、Neuralink、美敦力（Medtronic）和雅培（Abbott）等領先企業的強大影響力，以及在研發方面的大量投入。此外，該地區還受益於腦機介面（BCI）等先進技術的早期應用、有利的監管支援以及神經系統疾病的高發生率，所有這些因素共同推動了對創新神經技術解決方案的強勁需求。
  • 在按產品類型分類的神經技術市場中，預計到 2025 年，神經刺激器類別將佔據最大的市場佔有率。

推動神經技術市場成長的因素

  • 神經系統疾病盛行率上升推動神經技術蓬勃發展：帕金森氏症、癲癇和阿茲海默症神經系統疾病盛行率的上升正在推動神經技術市場顯著成長。隨著患者數量的增加，對先進診斷工具、監測系統和有效治療方案的需求也隨之增加。這推動了神經影像系統、神經刺激設備和腦機介面（BCI）技術的應用，最終加速創新並擴大整體市場成長。
  • 腦監測與介面技術的進步：腦監測與介面技術的進步顯著提升了腦部相關解決方案的準確性、效率和易用性，從而極大地推動了神經技術市場的發展。腦機介面（BCI）、先進的腦電圖（EEG）系統和即時神經影像技術的創新，使得神經系統疾病患者的診斷、治療和溝通得到改善。此外，人工智慧與穿戴式科技的融合，正將其應用範圍從醫療領域擴展到遊戲、認知增強和人機互動等領域，從而推動這些領域的應用，並促進整體市場成長。
  • 對神經技術新創企業的投資和資金籌措增加：對神經技術新創企業的投資和資金籌措增加，正在推動快速創新、產品開發和商業化，從而加速整個市場的發展。強而有力的資金支持使Neuralink和Synchron等公司能夠推進腦機介面（BCI）和下一代神經設備等尖端解決方案的開發。臨床試驗、監管核准和全球部署也得到了支持，提高了神經技術解決方案的可用性和應用率，最終推動市場成長。

神經技術市場報告細分

這份神經技術市場報告全面概​​述了全球神經技術市場，重點分析了關鍵趨勢、成長要素、挑戰和機會。報告涵蓋了按產品類型（神經刺激器{脊髓刺激設備、深部腦刺激器、薦骨神經刺激器、迷走神經刺激設備等}、義肢、腦機介面 (BCI) 系統、神經影像系統）、應用領域（癲癇、帕金森氏症、阿茲海默症、睡眠障礙等）、最終用戶（醫院、居家照護、復健中心等）和地區分類的詳細市場。報告深入分析了北美、歐洲和亞太等主要市場的競爭格局、監管環境和市場動態，並詳細介紹了主要行業參與企業及其最新產品創新，為企業提供關鍵數據，以識別市場潛力、制定戰略規劃並把握快速成長的神經技術市場中的新興機會。

神經技術是指直接與神經系統（尤其是大腦）交互，以監測、理解或控制神經活動的技術。這包括腦機介面（BCI）、神經影像系統和神經刺激設備等工具，這些工具廣泛應用於醫療、研究和認知領域。

帕金森氏症、癲癇和阿茲海默症神經系統疾病的日益普遍，顯著增加了對先進診斷和治療方案的需求，推動了神經技術的應用。尤其是在人口老化和全球患者數量持續成長的背景下，醫療保健系統越來越依賴能夠實現早期診斷、持續監測和標靶治療的技術。這加速了神經影像系統、神經刺激設備和其他先進神經學工具在醫院和研究機構的應用。

同時，腦機介面（BCI）和神經影像系統等領域的持續技術進步，正在提升這些解決方案的準確性、效率和易用性。即時腦波訊號處理、人工智慧分析、小型化穿戴式裝置和非侵入式介面等技術的進步，使得神經技術不僅在臨床環境中，而且在居家照護和消費應用中也更加普及。這些創新正在拓展其應用範圍，從傳統醫學領域延伸至認知增強、心理健康和人機互動等領域。

此外，對Neuralink和Synchron等創新公司的投資和資金籌措不斷增加，正在加速產品開發、臨床試驗和商業化進程。創業投資的日益成長和策略夥伴關係的建立，使新創公司能夠快速擴張，更快地將下一代產品推向市場，並拓展業務版圖。這些因素共同建構了一個強大且充滿活力的生態系統，促進創新，提高技術可近性，擴大應用範圍，最終推動全球神經技術市場的永續發展。

神經技術市場目前的市場動態和趨勢是什麼？

神經技術市場總體上受到癲癇、阿茲海默症和帕金森氏症等神經系統疾病日益普遍的推動，這大大增加了對準確和連續腦監測解決方案的需求。

根據世界衛生組織（WHO，2024）提供的數據，估計全球每年有 500 萬人被診斷出患有癲癇。

此外，根據阿茲海默症協會（2026）的數據，到2026年，美國將有超過700萬人患有阿茲海默症，預計到2050年，這一數字將接近1,300萬。在癲癇領域，對持續腦部監測和癲癇發作檢測的需求推動了腦電圖系統、植入式神經刺激設備和即時追蹤技術的應用。同樣，阿茲海默症負擔的加重也促使人們更多地使用神經影像工具和認知功能評估技術進行早期診斷和疾病進展監測。所有這些疾病都需要長期管理，因此對神經技術解決方案的需求持續存在。因此，患者數量的成長，以及對改善臨床療效和生活品質的需求，正在加速創新，並推動神經技術在醫療保健系統中的應用。

此外，腦監測和介面技術的進步顯著推動了整個神經技術市場的發展，提高了腦相關解決方案的準確性、擴充性和實際應用性。腦機介面（BCI）、先進的腦電圖（EEG）系統和人工智慧整合神經影像技術的創新，使得腦波訊號解碼更加快速且準確，從而增強了診斷、復健和溝通支援。這些進步使得裝置更加微創、穿戴式且易於使用，從而在醫院、研發甚至消費應用領域中得到更廣泛的應用。例如，2024年1月，Neuralink成功植入了首例人類大腦晶片，這標誌著臨床BCI發展的一個重要里程碑。

此外，對神經技術新創企業的投資和資金籌措增加，透過加速創新、臨床開發和先進解決方案的商業化，顯著推動了整體市場的發展。大規模的資金籌措使企業能夠擴大研發規模、擴大臨床試驗範圍，並更快地將下一代產品推向市場。例如，Neuralink 於 2025 年 6 月籌集了 6.5 億美元，用於支持其腦植入研發和臨床試驗；隨後在 2026 年 4 月又獲得了 6.5 億美元的 E 輪資金籌措，以進一步擴大其研發和全球部署。因此，預計這些因素將在預測期內推動整個神經技術市場的發展。

然而，侵入性手術帶來的風險是神經技術市場的主要阻礙因素。這是因為將裝置植入大腦和神經系統可能導致感染疾病、組織損傷和恢復期延長等併發症。這些安全隱患降低了患者的接受度，限制了其在臨床環境中的廣泛應用。此外，嚴格的產品核可監管流程也進一步減緩了市場成長。神經技術設備必須經過廣泛的臨床試驗、漫長的評估期以及嚴格的合規要求，以確保其安全性和有效性。這會延緩商業化進程，增加企業的研發成本，進而阻礙創新和市場擴張。

神經技術市場細分分析

按產品類型、應用程式、最終用戶和地區分類。

神經技術市場區域分析

北美神經技術市場趨勢

預計到2025年，北美將佔據神經技術市場39%的佔有率，成為所有地區中最大的市場佔有率。北美預計將成為神經技術市場的主要驅動力，這得益於其先進的醫療保健基礎設施、Neuralink、美敦力（Medtronic）和雅培（Abbott）等領先企業的強大影響力，以及對研發的大量投入。此外，該地區還受益於腦機介面（BCI）等先進技術的早期應用、有利的監管支援以及較高的神經系統疾病盛行率，所有這些因素共同推動了對創新神經技術解決方案的強勁需求。

根據美國疾病管制與預防中心（CDC，2024 年）的數據，美國約有 300 萬成年人患有癲癇。

此外，根據帕金森氏症基金會（2026年）提供的數據，美國有超過110萬人患有帕金森氏症。在癲癇領域，抗藥性病例的不斷增加加速了基於神經技術的治療方法的應用，例如能夠即時檢測和控制癲癇發作的響應式神經刺激系統、迷走神經刺激以及連續腦電圖（EEG）監測設備。同樣，在帕金森氏症領域，人們對深部腦部刺激（DBS）、穿戴式運動追蹤感測器和腦機介面（BCI）系統等技術的需求日益成長，這些技術有助於控制震顫、僵硬和運動遲緩等運動症狀，並提高患者的生活品質。除了這兩種疾病日益加重的全球負擔外，封閉回路型神經調控、人工智慧驅動的腦監測以及微創神經刺激設備的進步正在拓展臨床應用，並促進早期診斷和個人化治療方案的發展。

此外，在北美，腦監測和腦機介面（BCI）技術的進步，以及對神經技術新創公司投資和資金籌措的增加，正大大加速神經技術市場的成長。高解析度神經記錄系統、封閉回路型神經刺激器和微創BCI等創新技術，使得神經系統疾病的診斷更加精準，治療更加及時，從而改善臨床療效，並拓展了癲癇、帕金森氏症、癱瘓和中風復健等疾病的應用範圍。

同時，大量創業投資和來自大型科技及醫療保健公司的策略性投資正推動著美國和加拿大新創企業、臨床試驗和產品商業化的快速發展，使北美成為全球神經技術創新中心。近期發展清晰地展現了這一勢頭。例如，Precision Neuroscience公司於2025年4月獲得FDA核准，其Layer 7 Cortical Interface（第七層皮層介面）是一款微創腦機介面，旨在用於神經映射和未來的治療應用，這標誌著先進腦監測技術在監管方面取得了重大進展。此外，NeuroVigil公司於2024年4月在美國推出了其iBrain™非侵入式腦監測系統，該系統獲得了B大規模資金籌措的支援。這表明投資者對擴充性的非侵入式神經技術解決方案充滿信心。

這些發展，加上持續流入 Neuralink、Synchron 等神經科技新創公司的資金，大大加強了北美在全球神經科技市場的領導地位。

歐洲神經技術市場趨勢

歐洲神經技術市場正經歷強勁且持續的成長，其主要驅動力包括神經系統疾病盛行率的上升、醫療保健投資的增加，以及醫院和研究機構對先進腦監測、神經刺激和神經影像技術的快速應用。健全的法規結構和諸如「地平線歐洲」（Horizo​​​​n Europe）等大規模公共資助舉措進一步促進了這一區域成長，這些計劃正在加速腦機介面、神經診斷和數位神經科學解決方案的創新。推動市場需求的主要因素是歐洲日益嚴重的失智症負擔。根據老年失智症基金會（2025）預測，到2025年，歐盟27國將居住9,065,706名失智症患者，預計到2050年，這一數字將顯著成長至14,335,788人。這凸顯了對基於先進神經技術的診斷、監測和治療性介入日益成長的需求。

歐洲近期的發展進一步推動了這一勢頭。例如，2026年4月，歐盟加強了關於統一的「歐盟神經技術戰略」的討論，旨在平衡創新與倫理管治，並加速神經技術在成員國的安全商業化。此外，2025年4月，一個在「地平線歐洲」計畫框架下運作的歐洲研究聯盟擴大了一項大型臨床試驗，該試驗整合了人工智慧驅動的神經影像學和基於生物標記的診斷技術，用於早期檢測包括失智症和帕金森氏症在內的神經退化性疾病，從而增強了全部區域轉化神經科學能力。

除了這些努力之外，日益加重的疾病負擔和持續的技術創新也幫助歐洲確立了其在全球神經技術市場的主要成長中心地位。

亞太地區神經技術市場趨勢

亞太地區正崛起為神經科技市場的主要驅動力，這主要得益於神經系統疾病盛行率的快速上升、醫療基礎設施的不斷完善，以及中國、日本、印度和韓國等國家對先進醫療技術投資的持續成長。該地區癲癇、帕金森氏症、中風和失智症疾病患者數量龐大，人們對早期診斷和治療重要性的認知也日益提高，從而對神經診斷和神經刺激設備產生了強勁的需求。此外，政府致力於醫療系統現代化、人工智慧驅動的腦監測技術日益普及，以及全球神經技術公司在亞太市場的不斷擴張，都進一步加速了市場成長。日本和韓國在神經影像學和腦機介面研究方面處於領先地位，而中國和印度由於醫療服務可近性的提高和神經系統疾病負擔的加重，正在經歷醫院神經技術應用的快速擴張。此外，確保具有成本效益的生產能力、增加臨床試驗以及創業投資投資湧入醫療技術新創企業，正在鞏固該地區作為神經技術創新和商業化主要中心的地位。

神經技術市場的主要參與者有哪些？

以下是神經技術市場的主要參與者。這些公司通常佔據最大的市場佔有率，並引領行業趨勢。

  • Neuralink Corp.
  • Synchron Inc.
  • Paradromics Inc.
  • Blackrock Neurotech LLC
  • Kernel Inc.
  • Emotiv Inc.
  • NeuroSky Inc.
  • OpenBCI Inc.
  • Neurable Inc.
  • BrainCo Inc.
  • NextMind (Snap Inc.)
  • Bitbrain Technologies SL
  • Advanced Brain Monitoring Inc.
  • Cognionics Inc.
  • g.tec medical engineering GmbH
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • 其他

競爭格局對神經技術市場有何影響？

神經科技市場的競爭格局日益活躍，創新驅動力也越來越強，這主要得益於成熟的醫療設備領導企業者、新興的神經科技新創公司以及進軍腦機介面和神經刺激領域的科技公司。美敦力、雅培、波士頓科學和NeuroPace等主導企業正致力於拓展其神經刺激產品組合，推出新一代脊髓刺激設備、深部腦部刺激系統和響應式神經刺激器。同時，Neuralink、Synchron和Precision Neuroscience等新創公司正不斷突破侵入式和微創腦機介面技術的界限。人工智慧驅動的腦監測、封閉回路型神經調控系統和穿戴式神經診斷設備的快速發展進一步加劇了競爭，這些技術能夠實現更個人化、即時的治療方法。醫療技術公司、學術研究機構和人工智慧公司之間的策略合作也在不斷增加，以加速臨床檢驗和監管核准。此外，創業投資的資金投入以及大型科技公司進軍其他產業，正在推動積極的創新週期，使市場競爭異常激烈且瞬息萬變。重點在於提高精準度、降低侵入性並拓展臨床應用。

神經技術市場近期發展趨勢

  • 2026年3月，中國核准了世界上第一個商用腦機介面（BCI）醫療設備，這標誌著神經技術從實驗階段轉向現實世界應用階段的轉變。
  • 2025 年 11 月，Synchron 獲得了 2 億美元的 D 輪資金籌措，以加速其 Stentrode BCI 平台的商業化，並總共籌集了超過 3 億美元，以推動 BCI 創新。

神經技術市場細分

  • 按產品類型分類的神經技術市場趨勢
  • 神經刺激器
  • 脊髓刺激設備
  • 深部腦部刺激器
  • 薦骨神經刺激器
  • 迷走神經刺激設備
  • 其他
  • 神經義肢
  • 腦機介面（BCI）系統
  • 神經影像系統
  • 神經技術的應用
  • 癲癇
  • 帕金森氏症
  • 阿茲海默症
  • 睡眠障礙
  • 其他
  • 接觸神經技術終端用戶
  • 醫院
  • 居家照護
  • 復健中心
  • 其他
  • 神經技術的區域趨勢
  • 北美神經技術市場
  • 美國神經技術市場
  • 加拿大神經技術市場
  • 墨西哥神經技術市場
  • 歐洲神經技術市場
  • 英國神經技術市場
  • 德國神經技術市場
  • 法國神經技術市場
  • 義大利神經技術市場
  • 西班牙神經技術市場
  • 其他歐洲神經技術市場
  • 亞太地區神經技術市場
  • 中國神經技術市場
  • 日本神經技術市場
  • 印度神經技術市場
  • 澳洲神經技術市場
  • 韓國神經技術市場
  • 亞太地區其他神經技術市場
  • 其他地區的神經技術市場
  • 南美洲神經技術市場
  • 中東神經技術市場
  • 非洲神經技術市場

影響分析

人工智慧驅動的創新與應用：

人工智慧驅動的創新正在改變神經技術市場，實現更精準的診斷、即時監測和個人化治療。人工智慧和機器學習演算法正日益整合到腦機介面、神經影像系統和神經刺激設備中，用於分析複雜的神經訊號、識別異常腦活動模式並預測疾病進展。在癲癇等應用中，人工智慧正被用於透過腦電圖 (EEG) 分析預測和自動檢測癲癇發作，從而實現快速臨床干預並改善患者預後。在帕金森氏症領域，人工智慧驅動的穿戴式感測器和運動追蹤系統有助於監測震顫和運動功能波動，從而實現自適應深部腦部刺激和個人化治療方法調整。此外，人工智慧透過改進磁振造影 (MRI) 和功能性磁振造影 (fMRI) 的解讀，增強了神經診斷影像能力，有助於早期發現阿茲海默症和腦腫瘤等疾病。在腦機介面 (BCI) 中，人工智慧演算法解碼神經訊號，使癱瘓或嚴重運動障礙患者能夠與外部裝置進行交流和操作。總體而言，人工智慧驅動的神經技術正在顯著提高準確性，縮短診斷時間，並支持封閉回路型、自我調節的神經治療系統的發展。

美國關稅對神經技術市場的影響分析：

對美國關稅對神經技術市場影響的分析表明，關稅正透過推高成本、擾亂全球供應鏈以及加速製造業向國內生產轉移，日益改變該行業的結構。腦機介面、神經刺激系統、腦電圖設備和植入式神經調控技術等神經技術設備高度依賴來自世界各地的電子元件、半導體和精密醫療設備組件。近期美國關稅政策（包括基本進口關稅和對主要貿易夥伴提高關稅）推高了醫療設備及相關神經技術系統的投入成本，直接影響製造商的利潤率和醫院的採購預算。由於神經技術供應鏈在很大程度上是國際一體化的，關稅會造成合規和定價壓力，延緩產品上市時間，並在生產基地搬遷時需要耗費巨資進行監管重新認證。此外，美國貿易政策的不確定性以及根據《232條款》調查不斷演變的貿易措施，正促使企業將生產在地化、供應商多元化並重新設計供應鏈，以降低關稅風險。然而，醫療設備核准的嚴格監管要求減緩了這些調整，進一步加劇了短期市場限制。總體而言，關稅推高了成本並重組了供應鏈，暫時減緩了神經技術市場的創新步伐，但同時也促進了長期的在地化和策略重組。

這項分析能為客戶帶來哪些好處？

  • 成本管理：透過了解關稅趨勢，客戶可以預測成本上漲，並據此調整定價策略，以確保盈利。
  • 供應鏈最佳化：透過尋找替代來源並實現供應鏈多元化，客戶可以減少對高關稅地區的依賴，增強自身抵禦能力。
  • 監管合規：專家指導幫助客戶應對不斷變化的法規環境，從而保持合規並避免潛在的法律挑戰。
  • 策略規劃：深入了解關稅的影響，使客戶能夠就製造地、夥伴關係和打入市場策略做出明智的決策。

神經技術市場報告要點

  • 神經技術市場目前市場規模分析（2025 年）及 8 年市場預測（2026 年至 2034 年）
  • 過去三年發生的主要產品和技術開發、併購、合作和合資企業
  • 主導神經技術市場的領導公司。
  • 神經技術市場的其他競爭者也面臨各種機會。
  • 哪些細分市場在 2025 年表現最佳？這些細分市場在 2034 年的表現又會如何？
  • 目前神經技術市場中哪些地區和國家表現最佳？
  • 企業應專注於哪些地區和國家，以尋求神經技術市場的未來成長機會？

關於神經技術市場的常見問題

1. 神經技術市場的成長率是多少？

  • 預計從 2026 年到 2034 年的預測期內，神經技術市場將以 14.26% 的年複合成長率成長。

2. 什麼是神經技術市場？

  • 全球神經技術市場預計將從 2025 年的 172.4061 億美元成長到 2034 年的 570.2968 億美元。

3. 哪個地區在神經科技市場中佔據最大的市場佔有率？

  • 北美地區預計將引領神經技術市場的發展，這得益於其先進的醫療保健基礎設施、Neuralink、美敦力（Medtronic）和雅培（Abbott）等領先企業的強大影響力，以及在研發方面的大量投入。此外，該地區還受益於腦機介面（BCI）等先進技術的早期應用、有利的監管支援以及神經系統疾病的高發生率，所有這些因素共同推動了對創新神經技術解決方案的強勁需求。

4. 神經技術市場的成長要素為何？

  • 帕金森氏症、癲癇和阿茲海默症神經系統疾病的日益普遍，顯著提升了對先進診斷和治療方案的需求，推動了神經技術的應用。同時，腦機介面（BCI）和神經影像系統等領域的持續技術進步，提高了這些方案的準確性、效率和易用性，使其在臨床和非臨床環境中都能得到更廣泛的應用。此外，對Neuralink和Synchron等創新公司的投資和資金籌措不斷增加，加速了產品開發、商業化和全球擴張。這些因素共同建構了一個強大的生態系統，支持創新，促進應用，並推動神經技術市場的整體成長。

5. 神經技術市場的主要企業有哪些？

  • 神經科技市場的主要市場參與企業包括：Neuralink Corp.、Synchron Inc.、Paradromics Inc.、Blackrock Neurotech LLC、Kernel Inc.、Emotiv Inc.、NeuroSky Inc.、OpenBCI Inc.、Neurable Inc.、BrainCo.、NextMind (Snaps Inc.)、Bitbtec Technologies SL. engineering GmbH、Natus Medical Incorporated、Nihon Kohden Corporation、Medtronic plc、Abbott Laboratories 和 Boston Scientific Corporation。

目錄

第1章：神經技術市場報告概述

第2章：神經技術市場執行摘要

第3章：神經技術市場關鍵因素分析

  • 神經技術市場促進因素
    • 神經系統疾病發生率上升
    • 腦監測和介面方面的技術進步
    • 增加對神經科技新創企業的投資和資金
  • 限制神經技術市場的因素與挑戰
    • 侵入性手術的風險
    • 產品核可的嚴格監管流程
  • 神經科技市場的機遇
    • 對於癱瘓、肌萎縮性側索硬化症和中風患者，恢復其溝通和運動功能具有越來越大的潛力。

第4章：影響分析

  • 人工智慧驅動的創新和應用
  • 美國關稅影響分析

第5章：監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章：神經技術市場中的波特五力競爭力分析

第7章：神經技術市場評估

  • 依產品類型
    • 神經刺激設備
    • 神經假體
    • 腦機介面（BCI）系統
    • 神經影像系統
  • 透過使用
    • 癲癇
    • 帕金森氏症
    • 阿茲海默症
    • 睡眠障礙
    • 其他
  • 最終用戶
    • 醫院
    • 居家照護
    • 復健中心
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 競爭情勢

第9章：新創企業資金籌措與投資趨勢

第10章：神經技術市場－公司與產品概況

  • Neuralink
  • Synchron
  • Paradromics Inc.
  • Blackrock Neurotech LLC
  • Kernel Inc.
  • Emotiv Inc.
  • NeuroSky Inc.
  • OpenBCI Inc.
  • Neurable Inc.
  • BrainCo Inc.
  • NextMind (Snap Inc.)
  • Bitbrain Technologies SL
  • Advanced Brain Monitoring Inc.
  • Cognionics Inc.
  • g.tec medical engineering GmbH
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation

第11章：KOL的觀點

第12章 專案方法

第13章：關於 DelveInsight

第14章 免責聲明與聯絡方式

Product Code: DIMDCL0923

Neurotechnology Market Summary

  • The global neurotechnology market is expected to increase from USD 17,240.61 million in 2025 to USD 57,029.68 million by 2034, reflecting strong and sustained growth.
  • The global neurotechnology market is growing at a CAGR of 14.26% during the forecast period from 2026 to 2034.
  • The rising prevalence of neurological disorders such as Parkinson's Disease, Epilepsy, and Alzheimer's Disease is significantly increasing the demand for advanced diagnostic and therapeutic solutions, thereby driving the adoption of neurotechnology. At the same time, continuous technological advancements in areas like Brain-Computer Interface and neuroimaging systems are enhancing the accuracy, efficiency, and usability of these solutions, making them more accessible across clinical and non-clinical settings. Additionally, growing investment and funding in innovative companies such as Neuralink and Synchron are accelerating product development, commercialization, and global expansion. Collectively, these factors are creating a strong ecosystem that supports innovation, increases adoption, and fuels the overall growth of the neurotechnology market.
  • The leading companies operating in the neurotechnology market include Neuralink Corp., Synchron Inc., Paradromics Inc., Blackrock Neurotech LLC, Kernel Inc., Emotiv Inc., NeuroSky Inc., OpenBCI Inc., Neurable Inc., BrainCo Inc., NextMind (Snap Inc.), Bitbrain Technologies S.L., Advanced Brain Monitoring Inc., Cognionics Inc., g.tec medical engineering GmbH, Natus Medical Incorporated, Nihon Kohden Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, and others.
  • North America is expected to dominate the neurotechnology market due to its advanced healthcare infrastructure, strong presence of leading companies such as Neuralink, Medtronic, and Abbott, and high investment in research and development. The region also benefits from early adoption of advanced technologies like Brain-Computer Interface, favorable regulatory support, and a high prevalence of neurological disorders, which collectively drive strong demand for innovative neurotechnology solutions.
  • In the product type segment of the neurotechnology market, the neurostimulation devices category is estimated to account for the largest market share in 2025.

Factors Contributing to the Growth of the Neurotechnology Market

  • Rising prevalence of neurological disorders leading to a surge in neurotechnology: The rising prevalence of neurological disorders such as Parkinson's Disease, Epilepsy, and Alzheimer's Disease is driving a significant surge in the neurotechnology market. As the number of patients increases, there is a growing need for advanced diagnostic tools, monitoring systems, and effective treatment solutions. This has led to higher adoption of neuroimaging systems, neurostimulation devices, and Brain-Computer Interface technologies, ultimately accelerating innovation and expanding the overall market growth.
  • Technological advancements in brain monitoring & interfaces: Technological advancements in brain monitoring and interfaces are significantly boosting the neurotechnology market by improving the accuracy, efficiency, and usability of brain-related solutions. Innovations in Brain-Computer Interface, advanced EEG systems, and real-time neuroimaging are enabling better diagnosis, treatment, and communication for patients with neurological conditions. Additionally, the integration of AI and wearable technologies is expanding applications beyond healthcare into areas like gaming, cognitive enhancement, and human-computer interaction, thereby increasing adoption and driving overall market growth.
  • Increasing investment & funding in neurotechnology startups: Increasing investment and funding in neurotechnology startups is accelerating the overall market by enabling rapid innovation, product development, and commercialization. Strong financial backing allows companies like Neuralink and Synchron to advance cutting-edge solutions such as the Brain-Computer Interface and next-generation neurodevices. It also supports clinical trials, regulatory approvals, and global expansion, which in turn increases the availability and adoption of neurotechnology solutions, ultimately driving market growth.

Neurotechnology Market Report Segmentation

This neurotechnology market report offers a comprehensive overview of the global neurotechnology market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (Neurostimulation Devices {Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others}, Neuroprosthetics, Brain-Computer Interface (BCI) Systems, and Neuroimaging Systems), Application (Epilepsy, Parkinson's, Alzheimer's, Sleep Disorders, and Others), End-Users (Hospitals, Homecare, Rehabilitation Centers, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing neurotechnology market.

Neurotechnology refers to technologies that interact directly with the nervous system, especially the brain, to monitor, understand, or influence neural activity. It includes tools such as Brain-Computer Interface, neuroimaging systems, and neurostimulation devices used for medical, research, and cognitive applications.

The rising prevalence of neurological disorders such as Parkinson's Disease, Epilepsy, and Alzheimer's Disease is significantly increasing the demand for advanced diagnostic and therapeutic solutions, thereby driving the adoption of neurotechnology. As the global patient pool continues to expand, particularly with aging populations, healthcare systems are increasingly relying on technologies that enable early diagnosis, continuous monitoring, and targeted treatment. This has boosted the uptake of neuroimaging systems, neurostimulation devices, and other advanced neurological tools across hospitals and research institutions.

At the same time, continuous technological advancements in areas like Brain-Computer Interface and neuroimaging systems are enhancing the accuracy, efficiency, and usability of these solutions. Improvements such as real-time brain signal processing, AI-driven analytics, miniaturized wearable devices, and non-invasive interfaces are making neurotechnology more accessible not only in clinical environments but also in home care and consumer applications. These innovations are expanding use cases beyond traditional healthcare into areas like cognitive enhancement, mental wellness, and human-computer interaction.

Additionally, growing investment and funding in innovative companies such as Neuralink and Synchron are accelerating product development, clinical trials, and commercialization efforts. Increased venture capital interest and strategic partnerships are enabling startups to scale rapidly, bring next-generation products to market faster, and expand geographically. Collectively, these factors are creating a strong and dynamic ecosystem that fosters innovation, improves accessibility, increases adoption rates, and ultimately fuels the sustained growth of the global neurotechnology market.

What are the latest Neurotechnology market dynamics and trends?

The neurotechnology market is being collectively driven by the rising prevalence of neurological disorders such as Epilepsy, Alzheimer's Disease, and Parkinson's Disease, which is significantly increasing the need for accurate and continuous brain monitoring solutions.

According to the data provided by the World Health Organization (2024), globally, an estimated 5 million people were diagnosed with epilepsy each year.

Additionally, according to the projections provided by the Alzheimer's Association (2026), more than 7 million Americans are living with Alzheimer's in 2026, and by 2050, this number is projected to rise to nearly 13 million. In epilepsy, the need for continuous brain monitoring and seizure detection has led to higher adoption of EEG systems, implantable neurostimulation devices, and real-time tracking technologies. Similarly, the growing burden of Alzheimer's disease is increasing the use of neuroimaging tools and cognitive assessment technologies for early diagnosis and disease progression monitoring. Both conditions require long-term management, which supports sustained demand for neurotechnology solutions. As a result, rising patient populations, coupled with the need for improved clinical outcomes and quality of life, are accelerating innovation and expanding the adoption of neurotechnology across healthcare systems.

Furthermore, the technological advancements in brain monitoring and interfaces are significantly boosting the overall neurotechnology market by improving the precision, scalability, and real-world applicability of brain-related solutions. Innovations in Brain-Computer Interface, advanced EEG systems, and AI-integrated neuroimaging are enabling faster and more accurate decoding of brain signals, which enhances diagnosis, rehabilitation, and assistive communication. These advancements are also making devices more minimally invasive, wearable, and user-friendly, thereby expanding their adoption across hospitals, research, and even consumer applications. For instance, in January 2024, Neuralink successfully implanted its first human brain chip, marking a major milestone in clinical BCI development.

Additionally, increasing investment and funding in neurotechnology startups is significantly boosting the overall market by accelerating innovation, clinical development, and commercialization of advanced solutions. Large funding rounds are enabling companies to scale R&D, expand clinical trials, and bring next-generation products to market faster. For instance, in June 2025, Neuralink raised $650 million to support brain implant research and clinical trials, followed by a $650 million Series E in April 2026 to further expand development and global reach. Thus, the factors mentioned above are expected to boost the overall market of neurotechnology during the forecast period.

However, the risks associated with invasive procedures act as a major limiting factor in the neurotechnology market because they involve surgical implantation in the brain or nervous system, which can lead to complications such as infections, tissue damage, and long recovery periods. These safety concerns reduce patient acceptance and limit widespread clinical adoption. Additionally, the stringent regulatory process for product approval further slows market growth, as neurotechnology devices must undergo extensive clinical testing, long evaluation timelines, and strict compliance requirements to ensure safety and efficacy. This delays commercialization and increases development costs for companies, thereby restraining faster innovation and market expansion.

Neurotechnology Market Segment Analysis

Neurotechnology Market by Product Type (Neurostimulation Devices {Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others}, Neuroprosthetics, Brain-Computer Interface (BCI) Systems, and Neuroimaging Systems), Application (Epilepsy, Parkinson's, Alzheimer's, Sleep Disorders, and Others), End-Users (Hospitals, Homecare, Rehabilitation Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Neurotechnology Market Regional Analysis

North America Neurotechnology Market Trends

North America is expected to account for the highest proportion of 39% of the Neurotechnology market in 2025, out of all regions. North America is expected to dominate the neurotechnology market due to its advanced healthcare infrastructure, strong presence of leading companies such as Neuralink, Medtronic, and Abbott, and high investment in research and development. The region also benefits from early adoption of advanced technologies like Brain-Computer Interface, favorable regulatory support, and a high prevalence of neurological disorders, which collectively drive strong demand for innovative neurotechnology solutions.

According to the data provided by the Centre for Disease Control and Prevention (2024), almost 3 million U.S. adults have epilepsy.

Additionally, as per the data provided by the Parkinson's Foundation (2026), Parkinson's disease affected more than 1.1 million people in the U.S. In epilepsy, the rising prevalence of drug-resistant cases is accelerating the adoption of neurotechnology-based interventions such as responsive neurostimulation systems, vagus nerve stimulation, and continuous EEG monitoring devices that help detect and control seizures in real time. Similarly, Parkinson's disease is fueling demand for technologies like deep brain stimulation (DBS), wearable motion-tracking sensors, and brain-computer interface systems that help manage motor symptoms such as tremors, rigidity, and bradykinesia while improving patient quality of life. The growing global burden of both disorders, coupled with advancements in closed-loop neuromodulation, AI-enabled brain monitoring, and minimally invasive neurostimulation devices, is expanding clinical applications and encouraging early diagnosis and personalized treatment approaches.

Additionally, in North America, technological advancements in brain monitoring and brain-computer interfaces (BCIs), along with increasing investment and funding in neurotechnology startups, are strongly accelerating the growth of the neurotechnology market. Innovations such as high-resolution neural recording systems, closed-loop neurostimulation devices, and minimally invasive BCIs are enabling more precise diagnosis and real-time treatment of neurological disorders, improving clinical outcomes and expanding applications in conditions like epilepsy, Parkinson's disease, paralysis, and stroke rehabilitation.

At the same time, strong venture capital inflows and strategic investments from major tech and healthcare companies are fueling rapid startup growth, clinical trials, and product commercialization in the U.S. and Canada, making North America a global innovation hub for neurotechnology. Recent developments highlight this momentum, for instance, in April 2025, Precision Neuroscience received FDA clearance for its Layer 7 Cortical Interface, a minimally invasive brain-computer interface designed for neural mapping and future therapeutic applications, marking a key regulatory milestone for advanced brain monitoring technology. Additionally, in April 2024, NeuroVigil launched its iBrain(TM) non-invasive brain monitoring system in the U.S., backed by major Series B funding, demonstrating strong investor confidence in scalable, non-invasive neurotechnology solutions.

These developments, combined with continuous funding inflows into companies such as Neuralink, Synchron, and other neurotech startups, are significantly strengthening North America's leadership in the global neurotechnology market.

Europe Neurotechnology Market Trend

The neurotechnology market in Europe is witnessing strong and sustained growth, driven by the rising prevalence of neurological disorders, increasing healthcare investment, and rapid adoption of advanced brain monitoring, neurostimulation, and neuroimaging technologies across hospitals and research institutions. The region's growth is further supported by a strong regulatory framework and significant public funding initiatives such as Horizon Europe, which are accelerating innovation in brain-computer interfaces, neurodiagnostics, and digital neurology solutions. A major underlying demand driver is the increasing burden of dementia across Europe; according to the Alzheimer Foundation (2025), an estimated 9,065,706 people with dementia lived in EU27 countries in 2025, and this number is projected to rise significantly to 14,335,788 people by 2050, highlighting the growing need for advanced neurotechnology-based diagnostics, monitoring, and therapeutic interventions.

Recent developments in Europe further reflect this momentum. For instance, in April 2026, the European Union intensified discussions on a unified EU Neurotechnology Strategy to balance innovation with ethical governance and accelerate safe commercialization of neurotechnologies across member states. Additionally, in April 2025, European research consortia under Horizon Europe expanded large-scale clinical trials integrating AI-enabled neuroimaging and biomarker-based diagnostics for early detection of neurodegenerative diseases, including dementia and Parkinson's disease, strengthening translational neuroscience capabilities across the region.

These initiatives, combined with rising disease burden and continuous technological innovation, are positioning Europe as a key growth hub for the global neurotechnology market.

Asia-Pacific Neurotechnology Market Trends

The Asia Pacific (APAC) region is emerging as a major growth driver for the neurotechnology market due to the rapidly increasing prevalence of neurological disorders, expanding healthcare infrastructure, and rising investments in advanced medical technologies across countries such as China, Japan, India, and South Korea. The region is witnessing strong demand for neurodiagnostic and neurostimulation devices driven by a large patient population affected by conditions like epilepsy, Parkinson's disease, stroke, and dementia, along with growing awareness of early diagnosis and treatment. Additionally, government initiatives to modernize healthcare systems, increasing adoption of AI-enabled brain monitoring technologies, and growing participation of global neurotechnology companies in APAC markets are further accelerating growth. Japan and South Korea are leading in neuroimaging and brain-computer interface research, while China and India are experiencing rapid expansion in hospital-based neurotechnology adoption due to improving healthcare access and rising neurological disease burden. Moreover, the availability of cost-effective manufacturing capabilities, increasing clinical trials, and growing venture capital funding for medtech startups are strengthening the region's position as a key hub for neurotechnology innovation and commercialization.

Who are the major players in the neurotechnology market?

The following are the leading companies in the neurotechnology market. These companies collectively hold the largest market share and dictate industry trends.

  • Neuralink Corp.
  • Synchron Inc.
  • Paradromics Inc.
  • Blackrock Neurotech LLC
  • Kernel Inc.
  • Emotiv Inc.
  • NeuroSky Inc.
  • OpenBCI Inc.
  • Neurable Inc.
  • BrainCo Inc.
  • NextMind (Snap Inc.)
  • Bitbrain Technologies S.L.
  • Advanced Brain Monitoring Inc.
  • Cognionics Inc.
  • g.tec medical engineering GmbH
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Others

How is the competitive landscape shaping the neurotechnology market?

The competitive landscape of the neurotechnology market is becoming increasingly dynamic and innovation-driven, shaped by the presence of established medical device leaders, emerging neurotech startups, and technology companies entering the brain-computer interface and neurostimulation space. Major players such as Medtronic, Abbott, Boston Scientific, and NeuroPace are focusing on expanding their neurostimulation portfolios with next-generation spinal cord stimulators, deep brain stimulation systems, and responsive neurostimulation devices, while startups like Neuralink, Synchron, and Precision Neuroscience are pushing the boundaries of invasive and minimally invasive brain-computer interface technologies. The competition is further intensified by rapid advancements in AI-powered brain monitoring, closed-loop neuromodulation systems, and wearable neurodiagnostic devices, which are enabling more personalized and real-time treatment approaches. Strategic collaborations between medtech companies, academic research institutes, and AI firms are also increasing, as firms aim to accelerate clinical validation and regulatory approvals. Additionally, venture capital funding and cross-sector participation from big tech companies are fueling aggressive innovation cycles, making the market highly competitive and fast-evolving, with a strong focus on improving accuracy, reducing invasiveness, and expanding clinical applications.

Recent Developmental Activities in the Neurotechnology Market

  • In March 2026, China approved the world's first commercial brain-computer interface medical device, highlighting the transition of neurotechnology from experimental stages to real-world deployment.
  • In November 2025, Synchron secured a $200 million Series D funding round to accelerate the commercialization of its Stentrode BCI platform, while also raising over $300 million in total funding to advance BCI innovation.

Neurotechnology Market Segmentation

  • Neurotechnology by Product Type Exposure
  • Neurostimulation Devices
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Others
  • Neuroprosthetics
  • Brain-Computer Interface (BCI) Systems
  • Neuroimaging Systems
  • Neurotechnology Application Exposure
  • Epilepsy
  • Parkinson's
  • Alzheimer's
  • Sleep Disorders
  • Others
  • Neurotechnology End-Users Exposure
  • Hospitals
  • Homecare
  • Rehabilitation Centers
  • Others
  • Neurotechnology Geography Exposure
  • North America Neurotechnology Market
  • United States Neurotechnology Market
  • Canada Neurotechnology Market
  • Mexico Neurotechnology Market
  • Europe Neurotechnology Market
  • United Kingdom Neurotechnology Market
  • Germany Neurotechnology Market
  • France Neurotechnology Market
  • Italy Neurotechnology Market
  • Spain Neurotechnology Market
  • Rest of Europe Neurotechnology Market
  • Asia-Pacific Neurotechnology Market
  • China Neurotechnology Market
  • Japan Neurotechnology Market
  • India Neurotechnology Market
  • Australia Neurotechnology Market
  • South Korea Neurotechnology Market
  • Rest of Asia-Pacific Neurotechnology Market
  • Rest of the World Neurotechnology Market
  • South America Neurotechnology Market
  • Middle East Neurotechnology Market
  • Africa Neurotechnology Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-powered innovations are transforming the neurotechnology market by enabling more precise diagnosis, real-time monitoring, and personalized treatment of neurological disorders. Artificial intelligence and machine learning algorithms are increasingly being integrated into brain-computer interfaces, neuroimaging systems, and neurostimulation devices to analyze complex neural signals, identify abnormal brain activity patterns, and predict disease progression. In applications such as epilepsy, AI is used in seizure prediction and automated detection through EEG analysis, allowing faster clinical intervention and improved patient outcomes. In Parkinson's disease, AI-driven wearable sensors and motion-tracking systems help monitor tremors and motor function fluctuations, enabling adaptive deep brain stimulation and personalized therapy adjustments. Additionally, AI enhances neurodiagnostic imaging by improving MRI and fMRI interpretation for early detection of conditions like Alzheimer's and brain tumors. In brain computer interfaces, AI algorithms decode neural signals to enable communication and control of external devices for patients with paralysis or severe motor impairment. Overall, AI-powered neurotechnology is significantly improving accuracy, reducing diagnostic time, and supporting the development of closed-loop, self-adjusting neurological treatment systems.

U.S. Tariff Impact Analysis on Neurotechnology Market:

The U.S. tariff impact analysis on the neurotechnology market shows that tariffs are increasingly reshaping the industry by raising costs, disrupting global supply chains, and accelerating manufacturing shifts toward domestic production. Neurotechnology devices such as brain computer interfaces, neurostimulation systems, EEG devices, and implantable neuromodulation technologies are heavily dependent on globally sourced electronic components, semiconductors, and precision medical device parts. Recent U.S. tariff policies (including baseline import duties and higher tariffs on key trading partners) have increased input costs for medical devices and related neurotechnology systems, directly affecting manufacturers' margins and hospital procurement budgets. Since a large portion of neurotechnology supply chains is internationally integrated, tariffs create compliance and pricing pressure, delay commercialization timelines, and require costly regulatory revalidation when production locations shift. Additionally, uncertainty around evolving trade measures under U.S. trade policy and Section 232 investigations is encouraging companies to localize manufacturing in the U.S., diversify suppliers, and redesign supply chains to reduce tariff exposure. However, these adjustments are slow due to strict regulatory requirements for medical device approval, which further amplify short-term market constraints. Overall, tariffs are acting as a cost-inflation and supply-chain restructuring factor, temporarily slowing innovation flow while pushing long-term localization and strategic restructuring in the neurotechnology market.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the neurotechnology market report study

  • Market size analysis for the current neurotechnology market size (2025), and market forecast for 8 years (2026 to 2034)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the neurotechnology market.
  • Various opportunities available for the other competitors in the neurotechnology market space.
  • What are the top-performing segments in 2025? How these segments will perform in 2034?
  • Which are the top-performing regions and countries in the current neurotechnology market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the neurotechnology market growth in the future.

Frequently Asked Questions for the Neurotechnology Market

1. What is the growth rate of the neurotechnology market?

  • The neurotechnology market is estimated to grow at a CAGR of 14.26% during the forecast period from 2026 to 2034.

2. What is the market for neurotechnology?

  • The global neurotechnology market is expected to increase from USD 17,240.61 million in 2025 to USD 57,029.68 million by 2034.

3. Which region has the highest share in the neurotechnology market?

  • North America is expected to dominate the neurotechnology market due to its advanced healthcare infrastructure, strong presence of leading companies such as Neuralink, Medtronic, and Abbott, and high investment in research and development. The region also benefits from early adoption of advanced technologies like Brain-Computer Interface, favorable regulatory support, and a high prevalence of neurological disorders, which collectively drive strong demand for innovative neurotechnology solutions.

4. What are the drivers for the neurotechnology market?

  • The rising prevalence of neurological disorders such as Parkinson's Disease, Epilepsy, and Alzheimer's Disease is significantly increasing the demand for advanced diagnostic and therapeutic solutions, thereby driving the adoption of neurotechnology. At the same time, continuous technological advancements in areas like Brain-Computer Interface and neuroimaging systems are enhancing the accuracy, efficiency, and usability of these solutions, making them more accessible across clinical and non-clinical settings. Additionally, growing investment and funding in innovative companies such as Neuralink and Synchron are accelerating product development, commercialization, and global expansion. Collectively, these factors are creating a strong ecosystem that supports innovation, increases adoption, and fuels the overall growth of the neurotechnology market.

5. Who are the key players operating in the neurotechnology market?

  • Some of the key market players operating in the neurotechnology market include Neuralink Corp., Synchron Inc., Paradromics Inc., Blackrock Neurotech LLC, Kernel Inc., Emotiv Inc., NeuroSky Inc., OpenBCI Inc., Neurable Inc., BrainCo Inc., NextMind (Snap Inc.), Bitbrain Technologies S.L., Advanced Brain Monitoring Inc., Cognionics Inc., g.tec medical engineering GmbH, Natus Medical Incorporated, Nihon Kohden Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, and others.

Table of Contents

1. Neurotechnology Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Neurotechnology Market Executive Summary

  • 2.1 Market at Glance

3. Neurotechnology Market Key Factors Analysis

  • 3.1 Neurotechnology Market Drivers
    • 3.1.1 Rising prevalence of neurological disorders
    • 3.1.2 Technological advancements in brain monitoring & interfaces
    • 3.1.3 Increasing investment & funding in neurotechnology startups
  • 3.2 Neurotechnology Market Restraints and Challenges
    • 3.2.1 Risks associated with invasive procedures
    • 3.2.2 Stringent regulatory process for product approval
  • 3.3 Neurotechnology Market Opportunity
    • 3.3.1 Growing potential in restoring communication and motor functions for patients with paralysis, ALS, and stroke

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Neurotechnology Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Neurotechnology Market Assessment

  • 7.1 By Product Type
    • 7.1.1 Neurostimulation Devices
      • 7.1.1.1 Spinal Cord Stimulators
      • 7.1.1.2 Deep Brain Stimulators
      • 7.1.1.3 Sacral Nerve Stimulators
      • 7.1.1.4 Vagus Nerve Stimulators
      • 7.1.1.5 Others
    • 7.1.2 Neuroprosthetics
    • 7.1.3 Brain-Computer Interface (BCI) Systems
    • 7.1.4 Neuroimaging Systems
  • 7.2 By Application
    • 7.2.1 Epilepsy
    • 7.2.2 Parkinson's
    • 7.2.3 Alzheimer's
    • 7.2.4 Sleep Disorders
    • 7.2.5 Others
  • 7.3 By End-Users
    • 7.3.1 Hospitals
    • 7.3.2 Homecare
    • 7.3.3 Rehabilitation Centers
    • 7.3.4 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States Neurotechnology Market Size in USD million (2023-2034)
      • 7.4.1.2 Canada Neurotechnology Market Size in USD million (2023-2034)
      • 7.4.1.3 Mexico Neurotechnology Market Size in USD million (2023-2034)
    • 7.4.2 Europe
      • 7.4.2.1 France Neurotechnology Market Size in USD million (2023-2034)
      • 7.4.2.2 Germany Neurotechnology Market Size in USD million (2023-2034)
      • 7.4.2.3 United Kingdom Neurotechnology Market Size in USD million (2023-2034)
      • 7.4.2.4 Italy Neurotechnology Market Size in USD million (2023-2034)
      • 7.4.2.5 Spain Neurotechnology Market Size in USD million (2023-2034)
      • 7.4.2.6 Rest of Europe Neurotechnology Market Size in USD million (2023-2034)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China Neurotechnology Market Size in USD million (2023-2034)
      • 7.4.3.2 Japan Neurotechnology Market Size in USD million (2023-2034)
      • 7.4.3.3 India Neurotechnology Market Size in USD million (2023-2034)
      • 7.4.3.4 Australia Neurotechnology Market Size in USD million (2023-2034)
      • 7.4.3.5 South Korea Neurotechnology Market Size in USD million (2023-2034)
      • 7.4.3.6 Rest of Asia-Pacific Neurotechnology Market Size in USD million (2023-2034)
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 Middle East Neurotechnology Market Size in USD million (2023-2034)
      • 7.4.4.2 Africa Neurotechnology Market Size in USD million (2023-2034)
      • 7.4.4.3 South America Neurotechnology Market Size In USD Million (2023-2034)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Neurotechnology Market Company and Product Profiles

  • 10.1 Neuralink Corp.
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 Synchron Inc.
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Paradromics Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Blackrock Neurotech LLC
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 Kernel Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Emotiv Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 NeuroSky Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 OpenBCI Inc.
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 Neurable Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 BrainCo Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 NextMind (Snap Inc.)
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 Bitbrain Technologies S.L.
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 Advanced Brain Monitoring Inc.
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 Cognionics Inc.
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 g.tec medical engineering GmbH
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 Natus Medical Incorporated
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 Nihon Kohden Corporation
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 Medtronic plc
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 Abbott Laboratories
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 Boston Scientific Corporation
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Neurotechnology Market in Global (2023-2034)
  • Table 2: Neurotechnology Market in Global by Product Type (2023-2034)
  • Table 3: Neurotechnology Market in Global by Application (2023-2034)
  • Table 4: Neurotechnology Market in Global by End-Users (2023-2034)
  • Table 5: Neurotechnology Market in Global by Geography (2023-2034)
  • Table 6: Neurotechnology Market in North America (2023-2034)
  • Table 7: Neurotechnology Market in the United States (2023-2034)
  • Table 8: Neurotechnology Market in Canada (2023-2034)
  • Table 9: Neurotechnology Market in Mexico (2023-2034)
  • Table 10: Neurotechnology Market in Europe (2023-2034)
  • Table 11: Neurotechnology Market in France (2023-2034)
  • Table 12: Neurotechnology Market in Germany (2023-2034)
  • Table 13: Neurotechnology Market in United Kingdom (2023-2034)
  • Table 14: Neurotechnology Market in Italy (2023-2034)
  • Table 15: Neurotechnology Market in Spain (2023-2034)
  • Table 16: Neurotechnology Market in the Rest of Europe (2023-2034)
  • Table 17: Neurotechnology Market in Asia-Pacific (2023-2034)
  • Table 18: Neurotechnology Market in China (2023-2034)
  • Table 19: Neurotechnology Market in Japan (2023-2034)
  • Table 20: Neurotechnology Market in India (2023-2034)
  • Table 21: Neurotechnology Market in Australia (2023-2034)
  • Table 22: Neurotechnology Market in South Korea (2023-2034)
  • Table 23: Neurotechnology Market in Rest of Asia-Pacific (2023-2034)
  • Table 24: Neurotechnology Market in the Rest of the World (2023-2034)
  • Table 25: Neurotechnology Market in the Middle East (2023-2034)
  • Table 26: Neurotechnology Market in Africa (2023-2034)
  • Table 27: Neurotechnology Market in South America (2023-2034)
  • Table 28: Competitive Landscape
  • Table 29: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Neurotechnology Market Drivers
  • Figure 2: Neurotechnology Market Restraints
  • Figure 3: Neurotechnology Market Opportunities
  • Figure 4: AI-Powered Innovations in the Neurotechnology Market
  • Figure 5: US Tariff Impact on Neurotechnology Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Neurotechnology Market in Global (2023-2034)
  • Figure 10: Neurotechnology Market in Global by Product Type (2023-2034)
  • Figure 11: Neurotechnology Market in Global by Application (2023-2034)
  • Figure 12: Neurotechnology Market in Global by End-Users (2023-2034)
  • Figure 13: Neurotechnology Market in Global by Geography (2023-2034)
  • Figure 14: Neurotechnology Market in North America (2023-2034)
  • Figure 15: Neurotechnology Market in the United States (2023-2034)
  • Figure 16: Neurotechnology Market in Canada (2023-2034)
  • Figure 17: Neurotechnology Market in Mexico (2023-2034)
  • Figure 18: Neurotechnology Market in Europe (2023-2034)
  • Figure 19: Neurotechnology Market in France (2023-2034)
  • Figure 20: Neurotechnology Market in Germany (2023-2034)
  • Figure 21: Neurotechnology Market in United Kingdom (2023-2034)
  • Figure 22: Neurotechnology Market in Italy (2023-2034)
  • Figure 23: Neurotechnology Market in Spain (2023-2034)
  • Figure 24: Neurotechnology Market in the Rest of Europe (2023-2034)
  • Figure 25: Neurotechnology Market in Asia-Pacific (2023-2034)
  • Figure 26: Neurotechnology Market in China (2023-2034)
  • Figure 27: Neurotechnology Market in Japan (2023-2034)
  • Figure 28: Neurotechnology Market in India (2023-2034)
  • Figure 29: Neurotechnology Market in Australia (2023-2034)
  • Figure 30: Neurotechnology Market in South Korea (2023-2034)
  • Figure 31: Neurotechnology Market in Rest of Asia-Pacific (2023-2034)
  • Figure 32: Neurotechnology Market in the Rest of the World (2023-2034)
  • Figure 33: Neurotechnology Market in the Middle East (2023-2034)
  • Figure 34: Neurotechnology Market in Africa (2023-2034)
  • Figure 35: Neurotechnology Market in South America (2023-2034)
  • Figure 36: Competitive Landscape
  • Figure 37: Startup Funding & Investment Trends